Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven PD, et al
Semaglutide cut the risk for worsening heart failure and CV death for adults with HF with preserved ejection fraction, according to data presented at the European Society of Cardiology Congress and simultaneously published in The Lancet
It will also be very interesting to watch developments on certain GLP-1 products that continue to be compounded under the rationale that certain compounded products are required to meet the individual needs of patients
GLP-1 agonism: Emerging hypotheses and limitations While GLP-1 RAs hold therapeutic promise for increasing lifespan and reducing the morbidity of age-related illness through action on multiple organ systems, tissue-specific effects of GLP-1R agonism are possible
Retatrutide vs Tirzepatide A common topic in peptide research discussions is the comparison of Retatrutide vs Tirzepatide